Novo Nordisk A/S NVO reported second-quarter 2025 earnings of 97 cents per American Depositary Receipt (ADR), which beat the Zacks Consensus Estimate of 93 cents. The company had reported earnings of ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

Share on Twitter Print Share by Email Share Back to top In spring 2025, the Food and Drug Administration (FDA) resolved and ended the ...

Learn more about how to get Ozempic, including who can take it and where to find it, plus cost issues and the latest safety concerns to know about.

Rybelsus (semaglutide): Rybelsus is an oral version of semaglutide, primarily used for managing type 2 diabetes. Like its injectable counterpart, it helps with weight loss by reducing hunger and ...